Could a cell cocktail stop type 1 diabetes before it starts?

NCT ID NCT06688331

First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This study tests whether a combination of special immune cells (Tregs) and a drug (rituximab) can delay or prevent type 1 diabetes in children aged 6–16 who are at high risk but still produce insulin normally. About 150 participants will be randomly assigned to one of four groups, including placebo, and followed for up to five years. The goal is to see if the treatment can keep blood sugar levels normal and delay the onset of diabetes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 1 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centrum Medyczne Medyk Sp. z o.o. S.K.

    RECRUITING

    Rzeszów, 35-326, Poland

  • Gornoslaskie Centrum Zdrowia Dziecka Im. Sw. Jana Pawla II Samodzielny Publiczny Szpital Kliniczny Nr 6 Slaskiego Uniwersytetu Medycznego W Katowicach

    NOT_YET_RECRUITING

    Katowice, 40-752, Poland

  • Pomorski Uniwersytet Medyczny w Szczecinie

    RECRUITING

    Szczecin, 71-252, Poland

  • Uniwersytecki Dzieciecy Szpital Kliniczny Im. L. Zamenhofa W Bialymstoku

    RECRUITING

    Bialystok, 15-269, Poland

  • Uniwersytecki Szpital Dzieciecy w Lublinie

    RECRUITING

    Lublin, 20-093, Poland

  • Uniwersytecki Szpital Kliniczny Im. Jana Mikulicza-Radeckiego We Wroclawiu

    RECRUITING

    Wroclaw, 50-556, Poland

  • Uniwersytecki Szpital Kliniczny w Opolu

    RECRUITING

    Opole, 45-401, Poland

  • Uniwersyteckie Centrum Kliniczne

    RECRUITING

    Gdansk, 80-211, Poland

  • Uniwersytet Medyczny W Lodzi

    RECRUITING

    Lodz, 90-419, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.